Efficacy and safety of IV ferumoxytol for adults with iron deficiency anemia previously unresponsive to or unable to tolerate oral iron.

A positive trend in favor of ferumoxytol was also demonstrated in the Cancer subgroup compared with placebo (ferumoxytol 51.7% vs. placebo 30.0%; P = 0.2478), although the difference was not statistically significant.

also in 6,774 other papers